Rite Aid announces unsecured notes offering in connection with its EnvisionRx acquisition

CAMP HILL, Pa. — Rite Aid announced Wednesday that it will fund in part the cash portion of its acquisition of EnvisionRx through the offering of $1.8 billion in senior unsecured notes due 2023. 

 

In the event the acquisition is not completed, Rite Aid has the ability to use the net proceeds to refinance certain of its existing indebtedness or to redeem the notes, the drug store operator noted. 

 

The acquisition is expected to close by September 2015, subject to regulatory approvals and other customary closing conditions.